Atrial fibrillation: Difference between revisions

Latest revision as of 20:15, 21 October 2024


Atrial Fibrillation Microchapters
Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atrial Fibrillation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Special Groups Postoperative AF Acute Myocardial Infarction Wolff-Parkinson-White Preexcitation Syndrome Hypertrophic Cardiomyopathy Hyperthyroidism Pulmonary Diseases Pregnancy ACS and/or PCI or valve intervention Heart failure

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram EKG Examples A-Fib with LBBB

Chest X Ray

Echocardiography

Holter Monitoring and Exercise Stress Testing

Cardiac MRI

Treatment

Rate and Rhythm Control

Cardioversion Overview Electrical Cardioversion Pharmacological Cardioversion

Anticoagulation Overview Warfarin Converting from or to Warfarin Converting from or to Parenteral Anticoagulants Dabigatran

Maintenance of Sinus Rhythm

Surgery Catheter Ablation AV Nodal Ablation Surgical Ablation Cardiac Surgery
Specific Patient Groups

Primary Prevention
Secondary Prevention

Supportive Trial Data

Cost-Effectiveness of Therapy

Case Studies

Case #1

Atrial fibrillation On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrial fibrillation

CDC on Atrial fibrillation

Atrial fibrillation in the news

Blogs on Atrial fibrillation

Directions to Hospitals Treating Atrial fibrillation

Risk calculators and risk factors for Atrial fibrillation

For patient information, click here. Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2] Laith Adnan Allaham, M.D.[3] Sem A.O.F. Rikken, M.D.[4]

Synonyms and keywords: AF; afib; lone fibrillator

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Atrial Fibrillation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Special Groups

Diagnosis

Treatment

Dabigatran

Ablation

Catheter Ablation | AV Nodal Ablation | Surgical Ablation

Surgery

Maze Open Heart Surgery

Secondary Prevention

Supportive Trial Data

Cost-effectiveness of Therapy

Case Studies

Case #1

Related Chapters

Template:WikiDoc Sources CME Category::Cardiology

@@ Line 1: / Line 1: @@
-{{Infobox_Disease |
+__NOTOC__
-  Name           = Atrial fibrillation |
-  DiseasesDB     = 1065 |
-  ICD10          = {{ICD10|I|48||i|30}} |
-  ICD9           = {{ICD9|427.31}} |
-  ICDO           = |
-  OMIM           = |
-  MedlinePlus    = 000184 |
-  eMedicineSubj  = |
-  eMedicineTopic = |
-  eMedicine_mult = |}}
+{| class="infobox" style="float:right;"
+|-
+|[[File:Siren.gif|30px|link=Atrial fibrillation resident survival guide]]||<br>||<br>
+|[[Atrial fibrillation resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
+|}
+{| class="infobox" style="float:right;"
+|-
+|[[Image:Heart conduct sinus.gif|150px|]]<BR><small>'''Sinus rhythm'''</small>
+|}
+{| class="infobox" style="float:right;"
+|-
+|[[Image:Heart conduct atrialfib.gif|150px]]<BR><small>'''Atrial fibrillation'''</small>
+|}
 {{Atrial fibrillation}}
+{{Patient}}
+{{CMG}} {{AE}} {{Anahita}} {{Laith}} {{SemRikken}}
-'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
+{{SK}} AF; afib; lone fibrillator
-{{CMG}}
+==[[Atrial fibrillation overview|Overview]]==
+==[[Atrial fibrillation historical perspective|Historical Perspective]]==
-'''Synonyms and related keywords''': AF, Afib, fib, PAF, paroxysmal afib, Lone fibrillator
+==[[Atrial fibrillation classification|Classification]]==
-==[[Atrial fibrillation overview|Overview]]==
 ==[[Atrial fibrillation pathophysiology|Pathophysiology]]==
-==[[Atrial fibrillation epidemiology and demographics|Epidemiology and demographics]]==
+==[[Atrial fibrillation causes|Causes]]==
-==[[Atrial fibrillation risk factors | Risk Factors]]==
+==[[Atrial fibrillation differential diagnosis|Differentiating Atrial Fibrillation from other Diseases]]==
-==[[Atrial fibrillation diagnosis|Diagnosis]]==
+==[[Atrial fibrillation epidemiology and demographics|Epidemiology and Demographics]]==
-[[Atrial fibrillation symptoms|Symptoms]] | [[Atrial fibrillation screening|Screening]] | [[Atrial fibrillation physical examination|Physical Examination]] | [[Atrial fibrillation laboratory tests|Laboratory Tests]] | [[Atrial fibrillation electrocardiogram|Electrocardiogram]] | [[Atrial fibrillation chest x ray|Chest X ray]] | [[Atrial fibrillation echocardiography or ultrasound|Echocardiography]] | [[Atrial fibrillation other imaging findings#Holter monitoring|Holter monitoring]] | [[Atrial fibrillation other imaging findings#Exercise stress testing|Exercise stress testing]]
-==Treatment==
+==[[Atrial fibrillation risk factors|Risk Factors]]==
-===[[Atrial fibrillation urgent treatment|Urgent treatment]]===
-===[[Atrial fibrillation overview of treatment|Overview and General Treatment Strategies]]===
+==[[Atrial fibrillation screening|Screening]]==
-===Anticoagulation===
+==[[Atrial fibrillation natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
-[[Atrial fibrillation anticoagulation]] | [[Warfarin]] | [[Dabigatran]]
-[[Dabigatran#Converting from or to Warfarin|Converting from or to Warfarin]] | [[Dabigatran#Converting from or to Parenteral Anticoagulants|Converting from or to Parenteral Anticoagulants]]
+==Special Groups==
+[[Postoperative atrial fibrillation|Postoperative AF]] | [[Atrial fibrillation acute myocardial infarction|Acute Myocardial Infarction]] | [[Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes|Wolff-Parkinson-White Preexcitation Syndromes]] | [[Atrial fibrillation hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]] | [[Atrial fibrillation hyperthyroidism|Hyperthyroidism]] | [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]] | [[Atrial fibrillation pregnancy|Pregnancy]] | [[Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention|Patients Presenting with ACS and/or PCI or Valve Intervention]]
-'''[[Dabigatran]]:''' [[dabigatran#Dosing|Dosing]] | [[Dabigatran#Surgery and Interventions|Discontinuation for Surgery and Interventions]] | [[Dabigatran#WARNINGS AND PRECAUTIONS| Warnings and Precautions]] | [[Dabigatran#Adverse Reactions|Adverse Reactions]] | [[Dabigatran#Use in Specific Populations|Use in Specific Populations Such as Pregnancy]] | [[Dabigatran#Overdosage|Overdosage]] | [[Clinical Pharmacology of Dabigatran|Clinical Pharmacology]] | [[FDA Review of Data From the RE-LY Trial on September 20th, 2010|FDA Review of the RE-LY Data]] | [[A comparison of the RE-LY and Rocket AF Trials ]] | [[Estimates of Cost Per Year of Life Saved for Dabigatran]]
+==Diagnosis==
+[[Atrial fibrillation history and symptoms|History and Symptoms]] | [[Atrial fibrillation physical examination|Physical Examination]] | [[Atrial fibrillation laboratory findings|Laboratory Findings]] | [[Atrial fibrillation electrocardiogram|Electrocardiogram]] | [[Atrial fibrillation EKG examples|EKG Examples]] | [[Atrial fibrillation with LBBB EKG examples|Afib with LBBB EKG Examples]] | [[Atrial fibrillation chest x ray|Chest X Ray]] | [[Atrial fibrillation echocardiography or ultrasound|Echocardiography]] | [[Atrial fibrillation other imaging findings|Holter Monitoring and Exercise Stress Testing]] |  [[Atrial fibrillation cardiac MRI|Cardiac MRI]]
-===Rate Control===
+==[[Atrial fibrillation overview of treatment|Treatment]]==
-[[Atrial fibrillation maintenance of sinus rhythm| Maintenance of Sinus Rhythm]] | [[Atrial fibrillation rate control| Rate Control]] | [[Atrial fibrillation cardioversion|Cardioversion]] | [[Atrial fibrillation invasive treatment|Invasive Treatment]] | [[Atrial fibrillation surgical treatment|Surgical Treatment]]
+===[[Atrial fibrillation rate control|Rate and Rhythm Control]]===
+[[Atrial fibrillation rate control|Rate Control]] | [[Atrial fibrillation maintenance of rate control and sinus rhythm|Maintenance of Sinus Rhythm]]
-===Special Considerations===
+===Cardioversion===
-[[Postoperative atrial fibrillation|Postoperative AF]]  |  [[Atrial fibrillation acute myocardial infarction|Acute Myocardial Infarction]]  |  [[Atrial fibrillation Wolff-Parkinson-White preexcitation syndromes|Wolff-Parkinson-White Preexcitation Syndromes]]  |  [[Atrial fibrillation hyperthyroidism|Hyperthyroidism]]  |  [[Atrial fibrillation pregnancy|Pregnancy]]  |  [[Atrial fibrillation hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]  |  [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]]
+[[Atrial fibrillation cardioversion|Overview]] | [[Atrial fibrillation electrical cardioversion|Electrical Cardioversion]] | [[Atrial fibrillation pharmacological cardioversion|Pharmacological Cardioversion]]
-==[[Atrial fibrillation follow-up and secondary prevention|Follow-Up and Secondary Prevention]]==
+===Anticoagulation===
+[[Atrial fibrillation anticoagulation|Overview]] | [[Warfarin]] | [[Dabigatran#Converting from or to Warfarin|Converting from or to Warfarin]] | [[Dabigatran#Converting from or to Parenteral Anticoagulants|Converting from or to Parenteral Anticoagulants]] | [[Dabigatran]]
-==[[Atrial fibrillation clinical trial data|Clinical Trial Data]]==
+===Dabigatran===
+[[dabigatran#Dosing|Dosing]] | [[Dabigatran#Surgery and Interventions|Discontinuation for Surgery and Interventions]] | [[Dabigatran#WARNINGS AND PRECAUTIONS| Warnings and Precautions]] | [[Dabigatran#Adverse Reactions|Adverse Reactions]] | [[Dabigatran#Use in Specific Populations|Use in Specific Populations Such as Pregnancy]] | [[Dabigatran#Overdosage|Overdosage]] | [[Clinical Pharmacology of Dabigatran|Clinical Pharmacology]] | [[FDA Review of Data From the RE-LY Trial on September 20th, 2010|FDA Review of the RE-LY Data]] | [[A comparison of the RE-LY and Rocket AF Trials ]] | [[Estimates of Cost Per Year of Life Saved for Dabigatran]]
-==Vote on and Suggest Revisions to the Current Guidelines==
+===Ablation===
-* [[The Living Guidelines: Diagnosis and Management of Atrial Fibrillation | The AF Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines]]
+[[Atrial fibrillation catheter ablation|Catheter Ablation]] | [[AV nodal ablation|AV Nodal Ablation]] | [[Atrial fibrillation surgical ablation|Surgical Ablation]]
-==Guideline Resources==
+===Surgery===
-*[http://content.onlinejacc.org/cgi/reprint/48/4/e149.pdf ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation] <ref name="pmid16908781">Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. (2006) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16908781 ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.] ''Circulation'' 114 (7):e257-354. [http://dx.doi.org/10.1161/CIRCULATIONAHA.106.177292 DOI:10.1161/CIRCULATIONAHA.106.177292] PMID: [http://pubmed.gov/16908781 16908781]</ref>
+[[Atrial fibrillation surgical treatment|Maze Open Heart Surgery]]
-*[http://circ.ahajournals.org/content/123/10/e269.full.pdf 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation] <ref name="pmid21382897">Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. (2011) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=21382897 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.] ''Circulation'' 123 (10):e269-367. [http://dx.doi.org/10.1161/CIR.0b013e318214876d DOI:10.1161/CIR.0b013e318214876d] PMID: [http://pubmed.gov/21382897 21382897]</ref>
+===[[Atrial fibrillation secondary prevention|Secondary Prevention]]===
-*[http://circ.ahajournals.org/content/117/8/1101.full.pdf ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter] <ref name="pmid18283199">Estes NA, Halperin JL, Calkins H, Ezekowitz MD, Gitman P, Go AS et al. (2008) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=18283199 ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society.] ''Circulation'' 117 (8):1101-20. [http://dx.doi.org/10.1161/CIRCULATIONAHA.107.187192 DOI:10.1161/CIRCULATIONAHA.107.187192] PMID: [http://pubmed.gov/18283199 18283199]</ref>
+===[[Atrial fibrillation supportive trial data|Supportive Trial Data]]===
+===[[Atrial fibrillation cost-effectiveness of therapy|Cost-effectiveness of Therapy]]===
+==Case Studies==
+[[Atrial fibrillation case study one|Case #1]]
 ==Related Chapters==
-* [[Atrial flutter]]
-* [[Ashman phenomenon]]
-==External links==
-* [http://www.americanheart.org/presenter.jhtml?identifier=4451 American Heart Association's page on atrial fibrillation]
-* [http://www.patient.co.uk/showdoc/23068682/ Atrial fibrillation]
-* [http://www.jr2.ox.ac.uk/bandolier/booth/booths/AF.html Bandolier: Evidence-based medicine resource on atrial fibrillation]
-==References==
+*[[Atrial flutter]]
-{{reflist|2}}
+*[[Ashman phenomenon]]
+*[[The Living Guidelines: Diagnosis and Management of Atrial Fibrillation | The AF Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines]]
 {{Electrocardiography}}
 {{Circulatory system pathology}}
-[[de:Vorhofflimmern]]
-[[fr:Fibrillation auriculaire]]
-[[it:Fibrillazione atriale]]
-[[nl:Boezemfibrilleren]]
-[[ja:心房細動]]
-[[no:Atrieflimmer]]
-[[pl:Migotanie przedsionków]]
-[[ro:Fibrilaţia Atrială]]
-[[fi:Eteisvärinä]]
-[[zh:心房颤动]]
-[[tr:Atriyal fibrillasyon]]
 {{WikiDoc Help Menu}}
 {{WikiDoc Sources}}
+[[CME Category::Cardiology]]
+[[Category:Arrhythmia]]
+[[Category:Cardiology]]
 [[Category:Electrophysiology]]
-[[Category:Cardiology]]
 [[Category:Emergency medicine]]
 [[Category:Up-To-Date]]
-[[Category:Up-To-Date cardiology]]
+[[Category:Up-To-Date Cardiology]]

v t e Electrocardiography
Overview	History of the EKG • EKG interpretation basics • Normal sinus rhythm
EKG Complexes	P wave • QRS complex • ST Segment • T wave • T wave alternans • Tombstone T wave • U wave Osborn wave • H wave • K wave • Delta wave NSSTW changes
EKG Intervals	PR Interval • QRS Interval • ST Interval • QT Interval
Conduction System & Bradycardia	Cardiac pacemaker • SA node • AV node• Bundle of His • Purkinje fibers • Sinus bradycardia • First Degree AV Block • Second Degree AV Block • Complete or Third-Degree AV Block • Concealed conduction • AV Junctional Rhythms • LBBB • LAHB • LPHB • RBBB • Trifascicular block
Atrial Arrhythmias	Sinus tachycardia • Premature Atrial Contractions (PACs) • Ectopic Atrial Rhythm • Paroxysmal Atrial Tachycardia (PAT) • Paroxysmal Atrial Tachycardia (PAT) with Block • Multifocal Atrial Tachycardia (MAT) • Atrial Flutter • Atrial Fibrillation • Wandering atrial pacemaker
Ventricular Arrhythmias	Differential Diagnosis of Tachycardia with a Wide QRS Complex • Accelerated Idioventricular Rhythm • Ventricular Parasystole • Premature Ventricular Contractions (PVCs) • Ventricular tachycardia • Ventricular Fibrillation • Sudden cardiac death
EKG Abnormalities in Disease States	Hypertrophy & Dilatation • Right atrial enlargement • Left atrial enlargement • Biatrial enlargement • Left Ventricular Hypertrophy • Right Ventricular Hypertrophy • Biventricular Hypertrophy • Acute myocardial infarction • NSTEMI • STEMI • Tombstone ST elevation • Right ventricular myocardial infarction • Atrial infarction Pre-excitation Syndromes • Wolff-Parkinson-White Syndrome • Lown Ganong Levine Syndrome • Mahaim Type Preexcitation Cardiomyopathies • Arrhythmogenic Right Ventricular Dysplasia • Dilated Cardiomyopathy • Hypertrophic Cardiomyopathy Drug Effects on the EKG • Adenosine • β-blockers • Digitalis • Quinidine • Procainamide • Disopyramide • Lidocaine • Tocainide and Mexiletine • Phenytoin • Encainide, Flecainide and Propafenone • Amiodarone • Bretylium • Ca Channel Blockers • Phenothiazines • Tricyclic Antidepressants • Lithium Congenital Heart Disease • Dextrocardia • Atrial Septal Defect • Ventricular Septal Defect • Tetralogy of Fallot • Conjoined Twins or Siamese Twins • Congenital heart block Electrolyte Disturbances • Hyperkalemia • Hypokalemia • Hypercalcemia • Hypocalcemia • Nonspecific Changes Other Heart Diseases • Pericarditis • Myocarditis • Tamponade • Heart Transplantation • Sick Sinus Syndrome • Long QT Syndrome Inherited Disease • Brugada Syndrome Systemic Diseases • CNS Disease • Cardiac Tumors Heart Transplantation • EKG Changes in patient with Heart Transplantation Exogenous Effects • Hypothermia • Chest Trauma • Insect Bites • Electric Injuries
Technical Issues and Potential Errors in Interpretation	Artifacts • Lead Placement Errors • The EKG in a Patient with a Pacemaker • EKG in athletes

Atrial fibrillation: Difference between revisions

Latest revision as of 20:15, 21 October 2024

Special Groups

Diagnosis

Cardioversion

Anticoagulation

Dabigatran

Ablation

Surgery

Case Studies

Related Chapters

Navigation menu